carnitine has been researched along with ifosfamide in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Charpentier, C; Harpey, JP; Kamoun, P; Rabier, D; Schlenzig, JS; Sewell, AC | 1 |
| Bähler, H; Cerny, T; Küpfer, A; Lauterburg, BH; Visarius, TM | 1 |
| Küpfer, A; Lauterburg, BH; Marthaler, NP; Visarius, T | 1 |
| Baldelli, AM; Bisonni, R; Canestrari, F; Catalano, V; De Gaetano, A; Ferraro, B; Giordani, P; Graziano, F; Lai, V; Mencarini, E; Rovidati, S; Silva, R; Testa, E | 1 |
| Gregurich, M; Hockenberry, MJ; Hooke, MC; McCarthy, K | 1 |
| Al-Shabanah, OA; Aldelemy, ML; Hafez, MM; Sayed-Ahmed, MM | 1 |
| Al-Harbi, MM; Al-Harbi, NO; Al-Hosaini, KA; Al-Rejaie, SS; Al-Shabanah, OA; Aldelemy, ML; Aleisa, AM; Hafez, MM; Sayed-Ahmed, MM | 1 |
| Al-Harbi, MM; Al-Harbi, NO; Al-Hosaini, KA; Al-Shabanah, OA; Al-Sharary, SD; Aldelemy, ML; Hafez, MM; Sayed-Ahmed, MM | 1 |
| Hockenberry, MJ; Hooke, MC; McCarthy, K; Taylor, O | 1 |
1 trial(s) available for carnitine and ifosfamide
| Article | Year |
|---|---|
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients.
Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Carnitine; Cisplatin; Fatigue; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms; Nootropic Agents; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2002 |
9 other study(ies) available for carnitine and ifosfamide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
L-carnitine: a way to decrease cellular toxicity of ifosfamide?
Topics: Animals; Carnitine; Dose-Response Relationship, Drug; Female; Glutarates; Humans; Ifosfamide; Injections, Intraperitoneal; Rats; Rats, Wistar | 1995 |
Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats.
Topics: Animals; Antineoplastic Agents, Alkylating; Caprylates; Carnitine; Carnitine O-Palmitoyltransferase; Humans; Ifosfamide; Male; Mitochondria, Liver; Palmitic Acid; Rats; Rats, Wistar; Succinic Acid; Thioglycolates | 1998 |
Increased urinary losses of carnitine during ifosfamide chemotherapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Carnitine; Humans; Ifosfamide; Male; Middle Aged | 1999 |
Carnitine plasma levels and fatigue in children/adolescents receiving cisplatin, ifosfamide, or doxorubicin.
Topics: Adenosine Triphosphate; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carnitine; Child; Cisplatin; Cohort Studies; Doxorubicin; Energy Metabolism; Fatigue; Female; Humans; Ifosfamide; Male; Neoplasms; Severity of Illness Index; Surveys and Questionnaires | 2009 |
Inhibition of gene expression of organic cation/carnitine transporter and antioxidant enzymes in oxazaphosphorines-induced acute cardiomyopathic rat models.
Topics: Animals; Cardiomyopathies; Carnitine; Creatine Kinase; Cyclophosphamide; Gene Expression; Ifosfamide; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Male; Organic Cation Transport Proteins; Rats; Rats, Wistar | 2012 |
Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Carnitine; Caspases; Catalase; Creatinine; Disease Models, Animal; Down-Regulation; Fanconi Syndrome; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; Ifosfamide; Kidney; Male; Nitrates; Nitric Oxide Synthase; Nitrites; Nitrosation; Oxidation-Reduction; Rats; Rats, Wistar; Signal Transduction | 2012 |
Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models.
Topics: Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Cardiomyopathies; Cardiotoxicity; Carnitine; Carnitine O-Palmitoyltransferase; Creatine Kinase, MB Form; Cyclophosphamide; Disease Models, Animal; Fatty Acid-Binding Proteins; Gene Expression Regulation; Ifosfamide; L-Lactate Dehydrogenase; Male; Malonyl Coenzyme A; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2014 |
Fatigue and carnitine levels over multiple cycles of chemotherapy in children and adolescents.
Topics: Adolescent; Antineoplastic Agents; Carnitine; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Fatigue; Female; Humans; Ifosfamide; Male; Neoplasms; Self Report | 2015 |